2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Adjuvant Therapy in HER2+ BC: Utilizing T-DM1 for Pts With Residual Disease vs. Extending Adjuvant Therapy With 1 yr of Neratinib vs. Adding Pertuzumab + SoC Trastuzumab - Which Option Provides Better Results?

21 views
July 13, 2020
Comments 0
Login to view comments. Click here to Login